Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne L Furman

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Cancer Investigation|July 1, 2006
Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patientsBurgess B Freeman, Najat C Daw, J Russell Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trialLars M Wagner, Catherine A Billups, Wayne L Furman, et al.
Journal of Pediatric Surgery|October 16, 2004
Tumor recurrence at thoracostomy tube insertion sites: a report of two pediatric casesAndrea A Hayes-Jordan, Najat C Daw, Wayne L Furman, et al.
Pediatric Blood & Cancer|July 14, 2016
Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicitiesRachel C Brennan, Ibrahim Qaddoumi, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Rare Tumors in Children: Progress Through CollaborationAlberto S Pappo, Wayne L Furman, Kris A Schultz, et al.
International Journal of Clinical Oncology|May 11, 2018
Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapyRosa Nguyen, M Beth McCarville, April Sykes, et al.
Children (Basel, Switzerland)|April 3, 2021
Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular CarcinomaPattamon Sutthatarn, Cara E Morin, Jessica Gartrell, et al.
Pediatric Blood & Cancer|October 14, 2004
Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapyAndrew M Davidoff, Bethany L Corey, Fredric A Hoffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Decision making by parents of children with incurable cancer who opt for enrollment on a phase I trial compared with choosing a do not resuscitate/terminal care optionScott H Maurer, Pamela S Hinds, Sheri L Spunt, et al.
Pediatric Blood & Cancer|October 2, 2012
Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastomaAtmaram S Pai Panandiker, Chris Beltran, Catherine A Billups, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Cancer Investigation|July 1, 2006
Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patientsBurgess B Freeman, Najat C Daw, J Russell Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trialLars M Wagner, Catherine A Billups, Wayne L Furman, et al.
Journal of Pediatric Surgery|October 16, 2004
Tumor recurrence at thoracostomy tube insertion sites: a report of two pediatric casesAndrea A Hayes-Jordan, Najat C Daw, Wayne L Furman, et al.
Pediatric Blood & Cancer|July 14, 2016
Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicitiesRachel C Brennan, Ibrahim Qaddoumi, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Rare Tumors in Children: Progress Through CollaborationAlberto S Pappo, Wayne L Furman, Kris A Schultz, et al.
International Journal of Clinical Oncology|May 11, 2018
Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapyRosa Nguyen, M Beth McCarville, April Sykes, et al.
Children (Basel, Switzerland)|April 3, 2021
Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular CarcinomaPattamon Sutthatarn, Cara E Morin, Jessica Gartrell, et al.
Pediatric Blood & Cancer|October 14, 2004
Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapyAndrew M Davidoff, Bethany L Corey, Fredric A Hoffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Decision making by parents of children with incurable cancer who opt for enrollment on a phase I trial compared with choosing a do not resuscitate/terminal care optionScott H Maurer, Pamela S Hinds, Sheri L Spunt, et al.
Pediatric Blood & Cancer|October 2, 2012
Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastomaAtmaram S Pai Panandiker, Chris Beltran, Catherine A Billups, et al.
Pageof 10